158 related articles for article (PubMed ID: 405552)
1. Lack of effect of thyroid hormones on the growth hormone response to thyrotropin-releasing hormone in acromegaly.
Carlson HE; Sowers JR; Rand RW
Metabolism; 1977 Jul; 26(7):801-5. PubMed ID: 405552
[TBL] [Abstract][Full Text] [Related]
2. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
Losa M; Alba-Roth J; Sobieszczyk S; Schopohl J; Müller OA; von Werder K
Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
[TBL] [Abstract][Full Text] [Related]
3. The pituitary-thyroid axis in acromegaly.
Eskildsen PC; Kruse A; Kirkegaard C
Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
[TBL] [Abstract][Full Text] [Related]
4. Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
Hulting AL; Theodorsson E; Werner S
J Intern Med; 1992 Sep; 232(3):229-35. PubMed ID: 1402619
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
Nedvídková J; Felt V
Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
[TBL] [Abstract][Full Text] [Related]
6. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
Snyder PJ; Utiger RD
J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.
Villabona CM; Soler J; Virgili N; Gómez JM; Montaña E; Navarro MA
Horm Res; 1992; 37(1-2):14-17. PubMed ID: 1398470
[TBL] [Abstract][Full Text] [Related]
8. Pituitary hormone responses to hypothalamic releasing hormones in acromegaly.
Cantalamessa L; Reschini E; Catania A; Giustina G
Acta Endocrinol (Copenh); 1976 Dec; 83(4):673-83. PubMed ID: 826061
[TBL] [Abstract][Full Text] [Related]
9. Interaction between the thyrotrophin-releasing hormone-induced growth hormone rise and dopaminergic drugs: studies in pathologic conditions of the animal and man.
Müller EE; Salerno F; Cocchi D; Locatelli V; Panerai AE
Clin Endocrinol (Oxf); 1979 Dec; 11(6):645-56. PubMed ID: 119594
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
[TBL] [Abstract][Full Text] [Related]
11. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
Merola B; Colao A; Cataldi M; Rossi E; Longobardi S; Caruso E; Lombardi G
Horm Res; 1992; 37(1-2):7-13. PubMed ID: 1356902
[TBL] [Abstract][Full Text] [Related]
12. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
Marek J; Límanová Z; Srámková J
Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
[TBL] [Abstract][Full Text] [Related]
13. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
[TBL] [Abstract][Full Text] [Related]
14. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
De Marinis L; Mancini A; Zuppi P; Fiumara C; Conte G; Sammartano L; Fabrizi ML; Valle D
Exp Clin Endocrinol Diabetes; 1996; 104(1):67-71. PubMed ID: 8750573
[TBL] [Abstract][Full Text] [Related]
15. Hypothalamic hormone interaction in acromegaly.
Gomez-Pan A; Tunbridge WM; Duns A; Hall R; Besser GM; Coy DH; Schally AV; Kastin AJ
Clin Endocrinol (Oxf); 1975 Sep; 4(5):455-60. PubMed ID: 170027
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Acta Endocrinol (Copenh); 1987 Sep; 116(1):53-8. PubMed ID: 2889308
[TBL] [Abstract][Full Text] [Related]
17. Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.
Hanew K; Aida M; Tano T; Yoshinaga K
Tohoku J Exp Med; 1977 Mar; 121(3):197-206. PubMed ID: 404727
[TBL] [Abstract][Full Text] [Related]
18. [Comparison with growth hormone responses to various drugs or substances in patients with active acromegaly (author's transl)].
Takahara J; Ogawa N; Hosogi H; Aoki Y; Yamauchi J
Nihon Naibunpi Gakkai Zasshi; 1975 Oct; 51(10):803-12. PubMed ID: 821792
[TBL] [Abstract][Full Text] [Related]
19. Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.
Utsumi A; Hanew K; Sugawara A; Shimizu Y; Murakami O; Ikeda H; Yoshinaga K
J Endocrinol Invest; 1992 Mar; 15(3):167-71. PubMed ID: 1624675
[TBL] [Abstract][Full Text] [Related]
20. Impaired glucose tolerance coincides with abnormal release of growth hormone following a glucose load as well as in response to TRH in acromegaly.
Zárate A; García IC; Morán C; Fonseca ME
Horm Metab Res; 1986 Jun; 18(6):400-1. PubMed ID: 3089892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
